Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,701 to 1,720 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysis. | Oncol Lett | 2019 | 31423180 | PubTator, text mining | PubMed |
| Interplay between c-Src and the APC/C co-activator Cdh1 regulates mammary tumorigenesis. | Nat Commun | 2019 | 31420536 | PubTator, text mining | PubMed |
| WHAMM initiates autolysosome tubulation by promoting actin polymerization on autolysosomes. | Nat Commun | 2019 | 31420534 | PubTator, text mining | PubMed |
| TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation. | EBioMedicine | 2019 | 31420300 | PubTator, text mining | PubMed |
| LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion. | Cancer Res | 2019 | 31409639 | PubTator, text mining | PubMed |
| Effect of the Large and Small T-Antigens of Human Polyomaviruses on Signaling Pathways. | Int J Mol Sci | 2019 | 31408949 | PubTator, text mining | PubMed |
| Transcriptome variation in human populations and its potential application in forensics. | J Appl Genet | 2019 | 31401728 | PubTator, text mining | PubMed |
| Role of Podocyte Injury in Glomerulosclerosis. | Adv Exp Med Biol | 2019 | 31399967 | PubTator, text mining | PubMed |
| ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer. | Proc Natl Acad Sci U S A | 2019 | 31399545 | PubTator, text mining | PubMed |
| HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms. | J Exp Clin Cancer Res | 2019 | 31395086 | PubTator, text mining | PubMed |
| The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042. | J Clin Med | 2019 | 31382448 | PubTator, text mining | PubMed |
| Endothelial Cell Mechano-Metabolomic Coupling to Disease States in the Lung Microvasculature. | Front Bioeng Biotechnol | 2019 | 31380363 | PubTator, text mining | PubMed |
| Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry. | Cells | 2019 | 31370342 | PubTator, text mining | PubMed |
| Dynamin-Like Protein B of Dictyostelium Contributes to Cytokinesis Cooperatively with Other Dynamins. | Cells | 2019 | 31357517 | PubTator, text mining | PubMed |
| Sodium homeostasis in the tumour microenvironment. | Biochim Biophys Acta Rev Cancer | 2019 | 31348974 | PubTator, text mining | PubMed |
| Markers of Cancer Cell Invasion: Are They Good Enough? | J Clin Med | 2019 | 31344926 | PubTator, text mining | PubMed |
| Polyethylenimine-coated superparamagnetic iron oxide nanoparticles impair in vitro and in vivo angiogenesis. | Nanomedicine | 2019 | 31326525 | PubTator, text mining | PubMed |
| Ampelopsin E Reduces the Invasiveness of the Triple Negative Breast Cancer Cell Line, MDA-MB-231. | Molecules | 2019 | 31323836 | PubTator, text mining | PubMed |
| MPZL1 is highly expressed in advanced gallbladder carcinoma and promotes the aggressive behavior of human gallbladder carcinoma GBC‑SD cells. | Mol Med Rep | 2019 | 31322261 | PubTator, text mining | PubMed |
| Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study. | BMC Neurol | 2019 | 31319795 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=86